HE4 Gene Overexpression in Ovarian Cancer

HE4 Gene Overexpression in Ovarian Cancer

Introduction: Ovarian cancer is one of the common malignancies within women and the fifth cause of cancer death in women all over the world. Recent developments in Genomics and Proteomics technologies have led to the identification of unknown candidate markers for the diagnosis of ovarian cancer. Hu...

Full description

Bibliographic Details
Main Authors:	A Shahi, E Moslemi, A Izadi
Format:	Article
Language:	fas
Published:	Shahid Sadoughi University of Medical Sciences 2016-03-01
Series:	Majallah-i Dānishgāh-i ’Ulūm-i Pizishkī-i Shahīd Ṣadūqī Yazd
Subjects:	HE4 Gene Ovarion cancer Tumor marker
Online Access:	http://jssu.ssu.ac.ir/browse.php?a_code=A-10-2262-1&slc_lang=en&sid=1

Similar Items

HE4 level in ascites may assess the ovarian cancer chemotherapeutic effect
by: Duanyang Liu, et al.
Published: (2018-06-01)

An SPRi Biosensor for Determination of the Ovarian Cancer Marker HE4 in Human Plasma
by: Beata Szymanska, et al.
Published: (2021-05-01)

Comparison of two immunoassays for the measurement of serum HE4 for ovarian cancer
by: Chloe E. Barr, et al.
Published: (2021-08-01)

The diagnosis and pathological value of combined detection of HE4 and CA125 for patients with ovarian cancer
by: Zheng Li-e, et al.
Published: (2016-01-01)

Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis
by: Emanuela Anastasi, et al.
Published: (2023-06-01)

Can the Determination of HE4 and CA125 Markers Affect the Treatment of Patients with Endometrial Cancer?
by: Aneta Cymbaluk-Płoska, et al.
Published: (2021-03-01)

An investigation of the anti-cancer effects of vitamin D on the expression of HE4 gene and the viability of ovarian cancer cell line A2780S
by: Maryam Yahyaie, et al.
Published: (2022-08-01)

Comparison of HE4, CA125, ROMA and CPH-I for Preoperative Assessment of Adnexal Tumors
by: Núria Carreras-Dieguez, et al.
Published: (2022-01-01)

Evaluation of He4 Use in the Diagnosis of Ovarian Cancer: First and Second Recurrence, and an Analysis of HE4 Concentration during Second- and Third-Line Chemotherapy
by: Anita Chudecka-Głaz, et al.
Published: (2023-01-01)

Prognostic Significance of HE4 Tissue Expression in Serous Epithelial Ovarian Carcinoma
by: Ankita Sethi, et al.
Published: (2022-04-01)

Role of HE4 and ROMA Score in Diagnosis of Ovarian Cancer in Egyptian Women
by: Nahla El-Attar, et al.
Published: (2021-01-01)

Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review
by: Vincent Dochez, et al.
Published: (2019-03-01)

Urine CA125 and HE4 for the Detection of Ovarian Cancer in Symptomatic Women
by: Chloe E. Barr, et al.
Published: (2023-02-01)

HE4 overexpression decreases pancreatic cancer Capan-1 cell sensitivity to paclitaxel via cell cycle regulation
by: Fengbiao Guo, et al.
Published: (2020-05-01)

Correlation of Preoperative HE-4 and CA125 with Ovarian Cancer Staging in Ahvaz Imam Khomeni Hospital
by: Fatemeh Cheraghi, et al.
Published: (2020-01-01)

The Application of HE4 in Diagnosis of Gynecological Pelvic Malignant Tumor
by: Shuyi WANG, et al.
Published: (2009-02-01)

Improving the Accessibility and Efficiency of Proton Irradiations for 4He/3He Thermochronology
by: C. L. Colleps, et al.
Published: (2024-02-01)

Role of BRCA Mutation and HE4 in Predicting Chemotherapy Response in Ovarian Cancer: A Retrospective Pilot Study
by: Francesco Plotti, et al.
Published: (2021-01-01)

Multi-Marker Longitudinal Algorithms Incorporating HE4 and CA125 in Ovarian Cancer Screening of Postmenopausal Women
by: Aleksandra Gentry-Maharaj, et al.
Published: (2020-07-01)

Predictive Value of HE4 in Platinum-Based Chemotherapy for Ovarian Cancer: A Systematic Review
by: Yue Han, et al.
Published: (2021-07-01)

HE4 (WFDC2) Promotes Tumor Growth in Endometrial Cancer Cell Lines
by: Sean Dowdy, et al.
Published: (2013-03-01)

Kinetics of HE4 and CA125 as prognosis biomarkers during neoadjuvant chemotherapy in advanced epithelial ovarian cancer
by: Jorge A. Alegría-Baños, et al.
Published: (2021-07-01)

Overexpression of centromere protein K (CENPK) in ovarian cancer is correlated with poor patient survival and associated with predictive and prognostic relevance
by: Yi-Chao Lee, et al.
Published: (2015-11-01)

The Performance of HE4 Alone and in Combination with CA125 for the Detection of Ovarian Cancer in an Enriched Primary Care Population
by: Chloe E. Barr, et al.
Published: (2022-04-01)

Plasma levels of MMP-7 and TIMP-1 in laboratory diagnostics and differentiation of selected histological types of epithelial ovarian cancers
by: Grażyna Ewa Będkowska, et al.
Published: (2017-06-01)

Utility of tumor marker HE4 and CA125 to predict staging in endometrioid adenocarcinoma of the uterus
by: Narges Zamani, et al.
Published: (2015-11-01)

High preoperative blood levels of HE4 predicts poor prognosis in patients with ovarian cancer
by: Kalapotharakos Grigorios, et al.
Published: (2012-08-01)

HE4 as a Biomarker for Endometrial Cancer
by: Roya Behrouzi, et al.
Published: (2021-09-01)

HE4 and CA-125 kinetics to predict outcome in patients with recurrent epithelial ovarian carcinoma: the META4 clinical trial
by: Michel Fabbro, et al.
Published: (2024-01-01)

ZNF703 promotes tumor progression in ovarian cancer by interacting with HE4 and epigenetically regulating PEA15
by: Shuang Wang, et al.
Published: (2020-11-01)

Predicting value of HE4 and CA125 markers for optimal cytoreductive surgery in ovarian cancer patients
by: Elham Saffarieh, et al.
Published: (2022-08-01)

Human Epididymis Secretory Protein 4 (HE4) Compromises Cytotoxic Mononuclear Cells via Inducing Dual Specificity Phosphatase 6
by: Nicole E. James, et al.
Published: (2019-03-01)

Usefulness of HE4 protein in differentiation of pelvic masses in woman
by: Andrzej Brenk, et al.
Published: (2019-04-01)

The Utility of Serum HE4 in Predicting Myometrial Invasion in Patients with Endometrial Cancer
by: Malihe Hasanzadeh Mofrad, et al.
Published: (2020-10-01)

Early clearance of serum HE4 and CA125 in predicting platinum sensitivity and prognosis in epithelial ovarian cancer
by: Yan Rong, et al.
Published: (2021-01-01)

Urine CA125 and HE4 for the Triage of Symptomatic Women with Suspected Endometrial Cancer
by: Kelechi Njoku, et al.
Published: (2022-07-01)

Knockdown of HE4 suppresses aggressive cell growth and malignant progression of ovarian cancer by inhibiting the JAK/STAT3 pathway
by: Aihong Wang, et al.
Published: (2019-09-01)

Assessment of levels of the tumor markers HE4 and CA125 considering staging, grading and histological types of endometrial cancer
by: Nabil Abdalla, et al.
Published: (2016-11-01)

Performance of the IOTA ADNEX model combined with HE4 for identifying early-stage ovarian cancer
by: Suying Yang, et al.
Published: (2022-09-01)

Combination of serum CST1 and HE4 for early diagnosis of endometrial cancer
by: Wenhui Zhong, et al.
Published: (2023-12-01)